Baseline Amyloid Levels Predict One-Year Clearance on Donanemab, Analysis Shows
A post hoc analysis of the TRAILBLAZER-ALZ 2 trial found that lower baseline amyloid, older age, fewer APOE ε4 alleles ...
A post hoc analysis of the TRAILBLAZER-ALZ 2 trial found that lower baseline amyloid, older age, fewer APOE ε4 alleles ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.